BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3091604)

  • 1. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
    Stump DC; Thienpont M; Collen D
    J Biol Chem; 1986 Sep; 261(27):12759-66. PubMed ID: 3091604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex.
    Stump DC; Thienpont M; Collen D
    J Biol Chem; 1986 Jan; 261(3):1267-73. PubMed ID: 3080422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
    Moroi M; Aoki N
    J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin.
    Eaton DL; Scott RW; Baker JB
    J Biol Chem; 1984 May; 259(10):6241-7. PubMed ID: 6373753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I
    Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
    Wun TC; Reich E
    J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D; Lijnen HR; Piérard L; de Foresta F; Demarsin E; Jacobs P; De Wilde M; Bollen A; Collen D
    J Biol Chem; 1987 Aug; 262(24):11779-84. PubMed ID: 3114253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo.
    Geiger M; Huber K; Wojta J; Stingl L; Espana F; Griffin JH; Binder BR
    Blood; 1989 Aug; 74(2):722-8. PubMed ID: 2752144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
    Vassalli JD; Dayer JM; Wohlwend A; Belin D
    J Exp Med; 1984 Jun; 159(6):1653-68. PubMed ID: 6374011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of urokinase by complex formation with human alpha1-antitrypsin.
    Clemmensen I; Christensen F
    Biochim Biophys Acta; 1976 Apr; 429(2):591-9. PubMed ID: 1083251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor of plasminogen activator in human arterial wall. II. Biochemical characterization.
    Okamura T; Nanno S; Sueishi K; Tanaka K
    Acta Pathol Jpn; 1984 Jul; 34(4):749-57. PubMed ID: 6237547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
    Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
    J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3.
    Stief TW; Radtke KP; Heimburger N
    Biol Chem Hoppe Seyler; 1987 Oct; 368(10):1427-33. PubMed ID: 3501295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
    Sudol M; Reich E
    Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition of activated protein C and urokinase for a heparin-dependent inhibitor.
    Geiger M; Heeb MJ; Binder BR; Griffin JH
    FASEB J; 1988 Apr; 2(7):2263-7. PubMed ID: 3350241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation.
    Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
    Thromb Haemost; 1985 Aug; 54(2):485-9. PubMed ID: 3936218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.